Medical News

RSS

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

The Guardian Research Network and Molecular Health have announced a collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities.

29 May 2015

Second phase of Nutrition Facts Education Campaign launched in Canada

The Honourable Tony Clement, President of the Treasury Board, on behalf of the Honourable Rona Ambrose, Minister of Health, today launched the second phase of the Nutrition Facts Education Campaign (NFEC) to help Canadians make more informed food choices for themselves and their families.

29 May 2015

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.

29 May 2015

AAWC educates public on current, evidence-based practices in wound care

Educating the community continues to be a major focus of the Association for the Advancement of Wound Care (AAWC), which was incorporated in 1995.

29 May 2015

PDA extends support to Johnson & Johnson Kilmer Conference on sterility assurance and sterilization

The Parenteral Drug Association (PDA) proudly announces that it will be a supporting organization of the Johnson & Johnson Kilmer Conference on sterility assurance and sterilization in 2016.

29 May 2015

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly and Company announced final results of the Phase III PROCLAIM trial that will also be discussed in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

29 May 2015

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating the range of treatment options represented in Lilly's diabetes portfolio will be presented in 79 abstracts on June 5-9, at the 75th American Diabetes Association (ADA)® Scientific Sessions in Boston.

29 May 2015

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce its financial results for its second quarter ended March 31, 2015, which includes revenue for three months of $2,180,276 and net income for the quarter of $264,340.

29 May 2015

Measuring kidney function and damage may help predict people at risk for heart disease

Simple measures of kidney function and damage may be just as good at predicting who is at risk for heart failure and death from heart attack and stroke as traditional tests of cholesterol levels and blood pressure, new Johns Hopkins Bloomberg School of Public Health-led research suggests.

29 May 2015

First European approval of drug to treat genetic kidney disease ADPKD

Otsuka Pharmaceutical Co., Ltd. announced that the European Commission has granted marketing authorisation for JINARC® (tolvaptan) for the treatment of ADPKD in adults who have chronic kidney disease (CKD) stage one to three at initiation of treatment with evidence of rapidly progressing disease

29 May 2015

Transportation Insight receives SDCE100 Award for second consecutive year

Transportation Insight, a leading global third-party logistics (3PL) provider, announces winning the SDCE100 Award for the second consecutive year from Supply & Demand Chain Executive magazine.

29 May 2015

Zimmer finalizes divestiture agreements in furtherance of pending acquisition of Biomet

Zimmer Holdings, Inc. announced today that it has finalized agreements with buyers to divest in the United States certain Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow System assets and Cobalt™ bone cement assets.

29 May 2015

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.

29 May 2015

Federal funding constraints may jeopardize nation's research enterprise, undermine patient care

Constraints in federal funding, compounded by declining clinical revenue, jeopardize more than the nation's research enterprise.

29 May 2015

Maetrics, Medical Cluster host innovative conference in Zurich, Switzerland

Maetrics, a leading international consulting firm focused on the life sciences sector, wrapped up a successful conference, "The cost of non-compliance -- How new regulation is reshaping the Medical Technology industry," today in Zurich.

29 May 2015

MIT, UCSD researchers use probiotics to detect cancer in the liver

Engineers at MIT and the University of California at San Diego have devised a new way to detect cancer that has spread to the liver, by enlisting help from probiotics — beneficial bacteria similar to those found in yogurt.

29 May 2015

New EU Clinical Trials Regulation may prove to be challenging for cancer research in Europe

The European Society for Medical Oncology, in collaboration with the European Organisation for Research and Treatment of Cancer, expressed their views on the EU Clinical Trials Regulation in an official position paper recently published in Annals of Oncology.

29 May 2015

New research shows wide variation in organ donation rates across the country

More than 123,000 Americans are currently waiting for lifesaving organ transplants, but 21 patients die each day because there aren't enough organs to go around. New research shows wide variation in the number of eligible organ donors whose loved ones consent to organ donation across the country.

29 May 2015

Larger studies needed to validate multigene testing for prediction of breast cancer risk

While advances in technology have made multigene testing, or "panel testing," for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal of Medicine say larger studies are needed in order to provide reliable risk estimates for counseling these patients.

29 May 2015

RI-MUHC researchers receive $1.5 million to develop glutamate biosensor platform for brain diseases

In the human brain and retina, glutamate is an important messenger that carries information from one neuron to another. The level of glutamate transmitted between neurons is crucial to cell communication: too high and neurons die, too low and the information is not communicated properly. In either case this can contribute to neurological diseases including stroke, glaucoma, and Alzheimer's.

29 May 2015

Medical News

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

Second phase of Nutrition Facts Education Campaign launched in Canada

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

AAWC educates public on current, evidence-based practices in wound care

PDA extends support to Johnson & Johnson Kilmer Conference on sterility assurance and sterilization

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

Measuring kidney function and damage may help predict people at risk for heart disease

First European approval of drug to treat genetic kidney disease ADPKD

Transportation Insight receives SDCE100 Award for second consecutive year

Zimmer finalizes divestiture agreements in furtherance of pending acquisition of Biomet

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Federal funding constraints may jeopardize nation's research enterprise, undermine patient care

Maetrics, Medical Cluster host innovative conference in Zurich, Switzerland

MIT, UCSD researchers use probiotics to detect cancer in the liver

New EU Clinical Trials Regulation may prove to be challenging for cancer research in Europe

New research shows wide variation in organ donation rates across the country

Larger studies needed to validate multigene testing for prediction of breast cancer risk

RI-MUHC researchers receive $1.5 million to develop glutamate biosensor platform for brain diseases

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News